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Suggested citation for this article: Noonan CW, Williamson 
DM, Henry JP, Wagner L, Marrie RA. The prevalence of 
multiple sclerosis in 3 US Communities: the role of vitamin 
D [response to letter]. Prev Chronic Dis 2010;7(4). http://
www.cdc.gov/pcd/issues/2010/jul/10_0096.htm.  Accessed 
[date].
In Reply:
We appreciate Dr Grant’s comments (1) on our descrip-
tive  analysis  of  multiple  sclerosis  (MS)  prevalence  in  3 
US  communities  (2).  Respectfully,  we  disagree  that  we 
misinterpreted the findings. As researchers, we are cau-
tious  about  speculating  beyond  the  presented  data  or 
offering policy recommendations that are not sufficiently 
supported by the findings.
Dr  Grant  focused  his  comments  on  2  aspects  of  our 
manuscript. First, he reiterates the similarities between 
our  findings  and  those  by  others  (3)  but  criticizes  the 
absence of a detailed comparison between the 2 data sets. 
The figure presented by Dr Grant supports our findings of 
a geographic gradient but does little to extend the argu-
ment that UV exposure is protective for MS. Dr Grant’s 
argument is based on replacing 1 exposure variable that 
is assigned at the population level, latitude, with another 
correlated variable, UV exposure.
Second,  Dr  Grant  notes  that  we  failed  to  suggest  a 
mechanism for the link. As indicated in our discussion (2), 
the precise mechanism whereby UV exposure is inversely 
associated with MS is unknown, but we agree that mount-
ing evidence suggests that vitamin D synthesis may play 
a role in this pathway (4). Dr Grant further suggests a 
seasonal interactive effect between UV-dependent vitamin 
D exposure and the Epstein-Barr virus. We are unclear 
as to how our manuscript provides a platform for such an 
argument in the absence of any individual-level exposure 
data regarding either factor. Dr Grant further argues that 
the suspected role of vitamin D as a protective factor for 
the risk of MS should inform the upcoming Institute of 
Medicine dietary reference intakes for vitamin D. We do 
not disagree with this assertion, but we trust the Institute 
of Medicine will consider all available data, including the 
risks  and  benefits  of  changing  vitamin  D  recommenda-
tions, in their reassessment of these dietary guidelines.
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